Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,291 papers from all fields of science
Search
Sign In
Create Free Account
Refractory Anaplastic Large Cell Lymphoma
Known as:
Anaplastic Large Cell Lymphoma T- and Null-cell Types Refractory
Anaplastic large cell lymphoma resistant to treatment.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
14 relations
Anaplasia
Atypical lymphocyte
Hematopoietic and Lymphoid Cell
Hematopoietic and Lymphoid Tissue
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Safety and effective salvage regimen comprising a novel combination of brentuximab vedotin, L‐asparaginase, and dexamethasone for refractory anaplastic large cell lymphoma, anaplastic lymphoma kinase…
K. Kawamoto
,
Takaharu Suzuki
,
+5 authors
J. Takizawa
Hematological Oncology
2018
Corpus ID: 53215496
Currently, the CHOP regimen (cyclophosphamide, vincristine, adriamycin, and prednisolone) is most commonly administered initial…
Expand
2017
2017
Evaluation of the Clinical and Immunological Parameters During Treatment Chronic Periodontitis by Camelyn Mouthwash
I. Kachkachishvili
,
B. Korsantia
,
M. Bakradze
,
L. Aladashvili
,
I. Taboridze
2017
Corpus ID: 54199292
The purpose of study is Evaluation of Clinical and Immunological effects of using Camelyn in Periodontology. Materials and…
Expand
2017
2017
PERBEDAAN KUALITAS HIDUP ANTARA PENDERITA HIPERTROPI KONKA INFERIOR PRA DAN PASCA OPERASI REDUKSI KONKA METODE RADIOFREKUENSI
Ratri H A Cahyaningtyas
2017
Corpus ID: 166206005
Latar Belakang: Hipertropi konka inferior masih merupakan masalah kesehatan di bidang THT karena akan menurunkan kualitas hidup…
Expand
2016
2016
PENGEMBANGAN MODEL PEMBELAJARAN GERAK DASAR MANIPULATIF (PGDM) UNTUK SISWA SD KELAS V
Amirzan Amirzan
2016
Corpus ID: 192821064
Penelitian ini bertujuan untuk mengembangkan sebuah model pembelajaran gerak dasar manipulatif untuk siswa SD kelas V yang…
Expand
2015
2015
Long‐term survival of a child with refractory anaplastic large cell lymphoma following therapy with an antisense oligonucleotide, topotecan, and vinblastine
G. Wróbel
,
R. Chaber
,
J. Rygier
,
Jolanta Bonar
,
K. Muszyńska-Rosłan
,
A. Chybicka
Hematological Oncology
2015
Corpus ID: 28775323
Anaplastic large cell lymphoma includes a subset of highly aggressive tumours and has a relapse rate of 30% at 2 years. Relapsed…
Expand
2011
2011
KONTRIBUSI MINAT BELAJAR, KEMAMPUAN AWAL SISWA DAN MOTIVASI BELAJAR TERHADAP HASIL BELAJAR MATEMATIKA PADA SISWA KELAS VIII SEMESTER II TAHUN AJARAN 2010/2011 DI MTs N WONOSEGORO BOYOLALI
Yudha Trishananto
2011
Corpus ID: 192703481
Penelitian ini bertujuan untuk: (1) menganalisis dan menguji kontribusi minat belajar, kemampuan awal siswa dan motivasi belajar…
Expand
2006
2006
Mechanistic Evaluation of Siplizumab (MEDI-507) Activity on Normal and Malignant T-Lymphocytes.
S. Hammond
,
Stacy Fuhrmann
,
S. Roff
,
P. Kiener
,
S. Coats
,
M. Kinch
2006
Corpus ID: 208387685
Siplizumab is a humanized monoclonal antibody that selectively binds human CD2 (huCD2), which is expressed on virtually all cells…
Expand
2003
2003
ANALISIS PENGARUH LOKASI, LINGKUNGAN PERUMAHAN DAN FASILITAS UMUM TERHADAP KEPUASAN KONSUMEN PADA PERUMAHAN BUKIT PERMATA PURI SEMARANG
Immanuel Benny Bayuardi
2003
Corpus ID: 193765930
Pembangunan perumahall yang layak !:Iebat. serasi dan teratur rnenjadi tnllggungjawab bersruna antara. pemerintah Swashl dan…
Expand
Review
2001
Review
2001
UCN-01 Kyowa Hakko Kogyo Co.
K. Grosios
Current opinion in investigational drugs
2001
Corpus ID: 41627330
Kyowa Hakko Kogyo is developing UCN-01, a selective but non-specific inhibitor of kinases with good activity against protein…
Expand
Highly Cited
1966
Highly Cited
1966
Gm(s) and Gm(t): Genetic Determinants of Human γ‐Globulin *
.L. Mårtensson
,
E. Loghem
,
H. Matsumoto
,
J. Nielsen
1966
Corpus ID: 73284020
Two genetic determinants of human γ‐globulin, Gm(s) and Gm(t), were identified.
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE